美国妇产科医师学会“妊娠期高血压疾病指南2013版”（1～5章）要点解读

doi:10.7504/fk2014090102

摘要/Abstract

摘要：

妊娠期高血压疾病是妊娠期常见的疾病，以高血压、水肿、蛋白尿、抽搐、昏迷、心肾功能衰竭，甚至发生母儿死亡为临床特点。在过去十年内，对子痫前期的认识已取得实质性的进展。但是，包括美国在内，对妊娠期高血压疾病的分类、诊断和处理方案仍不规范，为了推出一个基于循证医学成果的最佳诊疗指南，2011年，美国妇产科医师学会（ACOG）成立了关于妊娠期高血压疾病工作组(American College of Obstetricians and Gynecologists’Task Force on Hypertension in Pregnancy)，该工作组由17名来自产科学、母胎医学、高血压、内科学、肾脏学、麻醉医学、生理学和患者宣传等领域的专家组成。主要有3个任务：（1）回顾全球已经发表的妊娠期高血压疾病领域的文献并进行循证分级评价，总结信息。（2）理解这些信息并形成临床指南。（3）确立实验室和临床研究的任务和方向。

关键词: 美国妇产科医师学会, 妊娠期高血压疾病工作组, 妊娠期高血压疾病

Key words: American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy

中图分类号:

Ｒ714.24

饶海英，邹虹，漆洪波. 美国妇产科医师学会“妊娠期高血压疾病指南2013版”（1～5章）要点解读[J]. 中国实用妇科与产科杂志, DOI: 10.7504/fk2014090102.

参考文献

［1］   Homer CS，Brown MA，Mangos G，et al. Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension［J］. J Hypertens, 2008,26: 295-302.

［2］   Kuo VS, Koumantakis G, Gallery ED. Proteinuria and its assessment in normal and hypertensive pregnancy［J］. Am J Obstet Gynecol ,1992, 167: 723-728.

［3］   Cnossen JS, Morris RK, ter Riet G, et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis［J］. CMAJ, 2008,178:701–711.

［4］   Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease［J］. Circulation, 2011,123:2856–2869.

［5］   Gonen R, Shahar R, Grimpel YI, et al. Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study［J］. BJOG, 2008,115:1465–1472.

［6］   Bujold E, Roberge S, Lacasse Y, et al. Prevention of preeclampsia and intra-uterine growth restriction with aspirin started in early pregnancy: a meta-analysis［J］. Obstet Gynecol ,2010,116: 402-414.

［7］    Spinnato JA, Freire S, Pinto E, et al. Antioxidant therapy to prevent preeclampsia: a randomized controlled trial［J］.Obestet Gynecol, 2007, 110:1311-1318.

［8］    Hofmeyr GJ, Lawrie TA, Atallah ÁN, et al. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems［J］. Cochrane Data-base of Systematic Reviews,2010, Issue 8. Art. No. CD001059. DOI: 10.1002/14651858.CD001059.

［9］    Collins R, Yusuf S, Peto R. Overview of randomised trials of diuretics in pregnancy［J］. Br Med J (Clin Res Ed) ,1985,290:17-23.

［10］   Bodnar LM, Catov JM, Simhan HN, et al. Maternal vitamin D deficiency increases the risk of preeclampsia［J］. J Clin Endocrinol Metab, 2007, 92:3517-3522.

［11］   Zavorsky GS, Longo LD. Adding strength training, exercise intensity, and caloric expenditure to exercise guide-lines in pregnancy［J］. Obstet Gynecol ,2011,117:1399-1402.

［12］    Magee L, Duley L. Oral beta-blockers for mild to moderate hypertension during pregnancy［J］. Coch Datab Syst Rev,2003, Issue 3. Art. No. CD002863. DOI: 10.1002/14651858. CD002863.

［13］    Meher S, Abalos E, Carroli G. Bed rest with or without hospitalisation for hypertension during pregnancy［J］. Cochr Datab Syst Rev, 2005, Issue 4. Art. No. CD003514. DOI: 10.1002/14651858.CD003514.

［14］    Signore C, Freeman RK, Spong CY. Antenatal testing-a re-evaluation: executive summary of a Eunice Kennedy Shriver National Institute of Child Health and Human Development Workshop［J］. Obstet Gynecol, 2009,113:687-701.

［15］   Sibai BM. Management of late preterm and early-term pregnancies complicated by mild gestational hypertension/pre-eclampsia［J］.Semin Perinatol ,2011,35:292-296.

［16］    Sibai BM, Barton JR. Expectant management of severe pre-eclampsia remote from term: patient selection, treatment, and delivery indications［J］. Am J Obstet Gynecol ,2007,196:514.e1-9.

［17］    Sibai BM. Evaluation and management of severe preeclampsia before 34 weeks' gestation. Publications Committee, Society for Maternal-Fetal Medicine［J］. Am J Obstet Gynecol, 2011,205:191-198.

［18］    Magee LA, Yong PJ, Espinosa V, et al. Expectant management of severe pre-eclampsia remote from term: a structured systematic review［J］. Hypertens Pregnancy，2009，28:312-347.

［19］    Amorim MM, Santos LC, Faundes A. Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia［J］. Am J   Obstet Gynecol, 1999,180: 1283-1288.

［20］   Newman MG, Robichaux AG, Stedman CM, et al. Perinatal outcomes in preeclampsia that is complicated by massive proteinuria［J］. Am J Obstet Gynecol ,2003;188:264-268.

［21］   Duley L, Gülmezoglu AM, Henderson-Smart DJ, et al. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia［J］. Cochr Datab Syst Rev,2010,Issue 11. Art. No.CD000025. DOI: 10.1002/ 14651858.CD000025.

（2014-06-25收稿）

[1]	漆洪波，胡小靖. 妊娠期高血压疾病产前保健的“六个重视”[J]. 中国实用妇科与产科杂志, 2021, 37(5): 512-514.
[2]	陈艺璇，牛建民. 妊娠期院外血压监测与管理[J]. 中国实用妇科与产科杂志, 2021, 37(5): 535-538.
[3]	赵建林, 石海君, 漆洪波. 美国妇产科医师学会《多胎妊娠指南（2021版）》要点解读#br#[J]. 中国实用妇科与产科杂志, 2021, 37(10): 1027-1031.
[4]	徐昉，漆洪波. ACOG《产科医生临床管理指南2019》“孕期重症监护”要点解读[J]. 中国实用妇科与产科杂志, 2020, 36(3): 245-250.
[5]	彭威，漆洪波. ACOG“妊娠期慢性高血压指南（2019）”解读[J]. 中国实用妇科与产科杂志, 2019, 35(9): 1014-1018.
[6]	杨怡珂，漆洪波. 美国妇产科医师学会（ACOG）“妊娠期高血压和子痫前期指南2019版”要点解读（第一部分）[J]. 中国实用妇科与产科杂志, 2019, 35(8): 895-899.
[7]	胡小靖，漆洪波. ACOG“正常分娩抗生素预防性应用”指南（2018）解读[J]. 中国实用妇科与产科杂志, 2019, 35(6): 666-671.
[8]	吴琳琳，周欣. 《妊娠期高血压疾病：国际妊娠期高血压研究学会分类、诊断和管理指南（2018）》解读[J]. 中国实用妇科与产科杂志, 2018, 34(7): 758-763.
[9]	朱方玉，漆洪波. ACOG实践简报“产后出血（2017版）”解读[J]. 中国实用妇科与产科杂志, 2018, 34(6): 623-627.
[10]	胡蓉，李笑天. 妊娠期高血压疾病降压的再认知及管理与子痫前期防范[J]. 中国实用妇科与产科杂志, 2018, 34(5): 484-488.
[11]	马国珺，林建华. 妊娠期高血压性心脏病的防与治[J]. 中国实用妇科与产科杂志, 2018, 34(5): 515-519.
[12]	刘騱遥，漆洪波. 美国妇产科医师学会“胎膜早破指南2018版”解读[J]. 中国实用妇科与产科杂志, 2018, 34(3): 266-269.
[13]	苟文丽，薛艳. 妊娠期高血压疾病国际指南与中国实践[J]. 中国实用妇科与产科杂志, 2017, 33(6): 559-563.
[14]	耿力，胡晏馨，马润玫. 妊娠期高血压疾病终止妊娠时机与方式[J]. 中国实用妇科与产科杂志, 2016, 32(8): 734-738.
[15]	陈红，张华，漆洪波. 美国妇产科医师学会“妊娠期恶心呕吐指南2015版”要点解读[J]. 中国实用妇科与产科杂志, 2016, 32(10): 929-933.